Climb Bio - 53 Year Dividend History | CLYM
Historical dividend payout and yield for Climb Bio (CLYM) since 1971. The current TTM dividend payout for Climb Bio (CLYM) as of October 14, 2024 is $0.00. The current dividend yield for Climb Bio as of October 14, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.365B |
$0.000B |
|
Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
